6-[4-[3-[(2R)-2-Methyl-1-pyrrolidinyl]propoxy]phenyl]-3(2H)-pyridazinone (ACI)

RNA, ([1′-de(6-amino-9H-purin-9-yl)]dA-(5′→5′)-sp-Am-Cm-Gm-Gm-Gm-Am-Cm-Am-(2′-deoxy-2′-fluoro)G-(2′-deoxy-2′-fluoro)U-(2′-deoxy-2′-fluoro)A-Um-Um-Cm-Um-Cm-Am-Gm-Um-Im-Am-(3′→3′)-sp-[1′-de(6-amino-9H-purin-9-yl)]dA), 3′-[O-[cis-4-[(3S,8S)-17-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-3,8-bis[[[2-[2-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]ethoxy]ethyl]amino]carbonyl]-1,6,11-trioxo-15-oxa-2,7,12-triazaheptadec-1-yl]cyclohexyl] hydrogen phosphorothioate], complex with RNA (Um-sp-(2′-deoxy-2′-fluoro)C-sp-Am-sp-(2′-deoxy-2′-fluoro)C-Um-(2′-deoxy-2′-fluoro)G-Am-Gm-Am-Am-Um-(2′-deoxy-2′-fluoro)A-Cm-(2′-deoxy-2′-fluoro)U-Gm-(2′-deoxy-2′-fluoro)U-Cm-(2′-deoxy-2′-fluoro)C-Cm-(2′-deoxy-2′-fluoro)G-sp-Um) (1:1) (ACI)

Immunoglobulin G1, anti-(antigen B7-H3) (human-Mus musculus monoclonal MGA271 heavy chain), disulfide with human-Mus musculus monoclonal MGA271 κ-chain, dimer (ACI)

AMG 181

Enfortumab vedotin

Immunoglobulin [1-aspartic acid], anti-(human respiratory syncytial virus fusion protein) (Lama glama heavy chain variable region fragment) fusion protein with peptide (synthetic 15-amino acid linker) fusion protein with immunoglobulin anti-(human respiratory syncytial virus fusion protein) (Lama glama heavy chain variable region fragment) fusion protein with peptide (synthetic 15-amino acid linker) fusion protein with immunoglobulin anti-(human respiratory syncytial virus fusion protein) (Lama glama heavy chain variable region fragment) (ACI)

DNA d(P-thio)(T-C-G-T-C-G-T-T-T-T-C-G-C-G-C-G-C-G-C-C-G) (ACI)

3-36-Peptide YY

Orticumab

C.I. Solvent Red 27 (7CI, 8CI)

(16E)-14-Methyl-20-oxa-5,7,14,27-tetraazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene (ACI)

GSK 249320 (ACI)

Ozoralizumab

Ublituximab

Vesencumab

Immunoglobulin G1, anti-(human protein TEM1 (tumor endothelial marker 1)) (human-mouse monoclonal MORAb-004 heavy chain), disulfide with human-mouse monoclonal MORAb-004 κ-chain, dimer (ACI)

Immunoglobulin, anti-(human glycoprotein NMB extracellular domain) (human monoclonal CR011 heavy chain), disulfide with human monoclonal CR011 κ-chain, dimer (ACI)

Filipin (7CI, 8CI, 9CI, ACI)

(-)-Oligomycin C

Teprotumumab